Terms: = Gastric cancer AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Treatment
43 results:
1. Implication of perineural invasion in patients with stage II gastric cancer.
Luo D; Wen YE; Chen H; Deng Z; Zheng J; Chen S; Peng J; Lian L
World J Surg Oncol; 2023 Nov; 21(1):372. PubMed ID: 38031044
[TBL] [Abstract] [Full Text] [Related]
2. Analysis of Characteristics and Risk Factors of Patients with Single gastric cancer and Synchronous Multiple gastric cancer among 14,603 Patients.
Song DH; Kim N; Jo HH; Kim S; Choi Y; Oh HJ; Lee HS; Yoon H; Shin CM; Park YS; Lee DH; Kang SH; Park YS; Ahn SH; Suh YS; Park DJ; Kim HH; Kim JW; Kim JW; Lee KW; Chang W; Park JH; Lee YJ; Lee KH; Kim YH; Ahn S; Surh YJ
Gut Liver; 2024 Mar; 18(2):231-244. PubMed ID: 36987384
[TBL] [Abstract] [Full Text] [Related]
3. Adenosine Receptor A2B Antagonist Inhibits the Metastasis of gastric cancer Cells and Enhances the Efficacy of Cisplatin.
Wang H; Tan F; Xu Y; Ma Y; Li Y; Xiao H
Technol Cancer Res Treat; 2023; 22():15330338221150318. PubMed ID: 36786018
[TBL] [Abstract] [Full Text] [Related]
4. Study on molecular biological mechanism of Chinese herbal medicines for the treatment of gastric precancerous lesions based on data mining and network pharmacology.
Zhang Q; Liu N; Wu D; Xu Z; Wang Y; Wang P
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 51(5):573-584. PubMed ID: 36581572
[TBL] [Abstract] [Full Text] [Related]
5. Initial Experience with Robotic Gastrectomy in Patients with gastric cancer: An Assessment of Short-Term Surgical Outcomes.
Isobe T; Murakami N; Minami T; Tanaka Y; Kaku H; Umetani Y; Kizaki J; Aoyagi K; Kashihara M; Fujita F; Akagi Y
Kurume Med J; 2022 Nov; 67(2.3):77-82. PubMed ID: 36123025
[TBL] [Abstract] [Full Text] [Related]
6. Benefit of laparoscopic compared to standard open gastric cancer surgery for sarcopenic patients: a propensity score-matching analysis.
Uchida T; Sekine R; Matsuo K; Kigawa G; Umemoto T; Tanaka K
Surg Endosc; 2022 Dec; 36(12):9244-9253. PubMed ID: 35840711
[TBL] [Abstract] [Full Text] [Related]
7. Difficulty in distinguishing malignant gastric lymphoma from advanced gastric cancer: Focusing on endoscopic findings of the Borrmann type.
Jung K; Choe IH; Park MI; Park SJ; Moon W; Kim SE; Kim JH; Seo KI
Medicine (Baltimore); 2021 Feb; 100(7):e24854. PubMed ID: 33607858
[TBL] [Abstract] [Full Text] [Related]
8. Pathological Findings of the Host Immune Reaction in the Tumor Microenvironment of Gastroenteropancreatic Neuroendocrine Neoplasms.
Hasegawa S; Kobayashi N; Okubo N; Tokuhisa M; Goto A; Kurita Y; Sato T; Hosono K; Endo I; Nakajima A; Ichikawa Y
Intern Med; 2021 Apr; 60(7):977-983. PubMed ID: 33162477
[TBL] [Abstract] [Full Text] [Related]
9. Distinguish the Role of Radiotherapy From Chemoradiotherapy for gastric cancer With Behavior of Metastasis-Indolent in Lymph Node.
Zhi Y; Lin Z; Ma J; Mou W; Chen X
Technol Cancer Res Treat; 2020; 19():1533033820959400. PubMed ID: 33148125
[TBL] [Abstract] [Full Text] [Related]
10. Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive cancers.
Lee SC; Shimasaki N; Lim JSJ; Wong A; Yadav K; Yong WP; Tan LK; Koh LP; Poon MLM; Tan SH; Ow SGW; Bharwani L; Yap YS; Foo MZQ; Coustan-Smith E; Sundar R; Tan HL; Chong WQ; Kumarakulasinghe NB; Lieow JLM; Koe PJX; Goh BC; Campana D
Clin Cancer Res; 2020 Sep; 26(17):4494-4502. PubMed ID: 32522887
[TBL] [Abstract] [Full Text] [Related]
11. Bibliometric Analysis of 100 Top-Cited Articles in gastric Disease.
Yuan F; Cai J; Liu B; Tang X
Biomed Res Int; 2020; 2020():2672373. PubMed ID: 32509853
[TBL] [Abstract] [Full Text] [Related]
12. HELICOBACTER PYLORI INFECTION AND gastric cancer PRECURSOR LESIONS: PREVALENCE AND ASSOCIATED FACTORS IN A REFERENCE LABORATORY IN SOUTHEASTERN BRAZIL.
Rodrigues MF; Guerra MR; Alvarenga AVR; Souza DZO; Costa RAVES; Cupolilo SMN
Arq Gastroenterol; 2019; 56(4):419-424. PubMed ID: 31800739
[TBL] [Abstract] [Full Text] [Related]
13. Prediction of platinum-resistance patients of gastric cancer using bioinformatics.
Pan J; Xiang Z; Dai Q; Wang Z; Liu B; Li C
J Cell Biochem; 2019 Aug; 120(8):13478-13486. PubMed ID: 30912200
[TBL] [Abstract] [Full Text] [Related]
14. [Pathological features of duodenal-type follicular lymphoma].
Zhang F; Luo DL; Chen Y; He J; Yan JH; Luo LQ; Luo XL; Liu YH
Zhonghua Bing Li Xue Za Zhi; 2019 Jan; 48(1):22-25. PubMed ID: 30641641
[No Abstract] [Full Text] [Related]
15. Gene regulatory network construction identified NFYA as a diffuse subtype-specific prognostic factor in gastric cancer.
Cao B; Zhao Y; Zhang Z; Li H; Xing J; Guo S; Qiu X; Zhang S; Min L; Zhu S
Int J Oncol; 2018 Nov; 53(5):1857-1868. PubMed ID: 30106137
[TBL] [Abstract] [Full Text] [Related]
16. Combining multi-dimensional data to identify a key signature (gene and miRNA) of cisplatin-resistant gastric cancer.
Zhou D; Li X; Zhao H; Sun B; Liu A; Han X; Cui Z; Yuan L
J Cell Biochem; 2018 Aug; 119(8):6997-7008. PubMed ID: 29693274
[TBL] [Abstract] [Full Text] [Related]
17. Minimally invasive surgery for gastric cancer: A comparison between robotic, laparoscopic and open surgery.
Parisi A; Reim D; Borghi F; Nguyen NT; Qi F; Coratti A; Cianchi F; Cesari M; Bazzocchi F; Alimoglu O; Gagnière J; Pernazza G; D'Imporzano S; Zhou YB; Azagra JS; Facy O; Brower ST; Jiang ZW; Zang L; Isik A; Gemini A; Trastulli S; Novotny A; Marano A; Liu T; Annecchiarico M; Badii B; Arcuri G; Avanzolini A; Leblebici M; Pezet D; Cao SG; Goergen M; Zhang S; Palazzini G; D'Andrea V; Desiderio J
World J Gastroenterol; 2017 Apr; 23(13):2376-2384. PubMed ID: 28428717
[TBL] [Abstract] [Full Text] [Related]
18. Clinical Outcome of Doublet and Triplet Neoadjuvant Chemotherapy for Locally Advanced gastric cancer.
Kim JS; Kang SH; Moon HS; Sung JK; Jeong HY; Sul JY
Korean J Gastroenterol; 2016 Nov; 68(5):245-252. PubMed ID: 27871160
[TBL] [Abstract] [Full Text] [Related]
19. [Predictive pre-treatment value of the Prognostic Nutritional Index on survival in gastric carcinoma].
Borda A; Borda F; Vila J; Fernández-Urién I; Zozaya JM; Guerra A
An Sist Sanit Navar; 2016; 39(2):227-35. PubMed ID: 27599950
[TBL] [Abstract] [Full Text] [Related]
20. A Randomized Phase II Study of FOLFOX With or Without the MET Inhibitor Onartuzumab in Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction.
Shah MA; Cho JY; Tan IB; Tebbutt NC; Yen CJ; Kang A; Shames DS; Bu L; Kang YK
Oncologist; 2016 Sep; 21(9):1085-90. PubMed ID: 27401892
[TBL] [Abstract] [Full Text] [Related]
[Next]
